Fuchs Dystrophy
18
4
4
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.6%
1 terminated out of 18 trials
90.9%
+4.4% vs benchmark
17%
3 trials in Phase 3/4
30%
3 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (18)
Descemet Endothelial Thickness Comparison Trial II
Study to Assess Safety and Tolerability of Multiple Doses of EO2002
OCT in Fuchs' Dystrophy
The Evaluation of Balanced Salt Solution During Cataract Surgery
FECD-TRACE: Fuchs' Endothelial Corneal Dystrophy TRAjectory and Correlation With Genotype in the United Kingdom
Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema
Association Between Fuchs' Endothelial Corneal Dystrophy Severity and Estrogen Exposure
Novel Diagnostics With Optical Coherence Tomography: Imaging the Anterior Eye
TTHX1114(NM141) in Combination With DWEK/DSO
Descemet Membrane Endothelial Keratoplasty vs. Descemet's Stripping With Endothelial Keratoplasty vs. Descemet Stripping Only
The ADVISE Study: Advanced Visualization In Corneal Surgery Evaluation
Femtolaser Assisted Keratoplasty Versus Conventional Keratoplasty
Cornea Donor Study
Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema
Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy
Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty
Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)
A Comparison Between Full Thickness and Partial Thickness Corneal Transplantation for Corneal Edema